Top

Journal of Interventional Cardiac Electrophysiology

Published in:

01-01-2017 | CASE REPORTS

Increased risk of ventricular fibrillation associated with RYTHMIQ™: lessons learned

Authors: Thomas Nguyen, Juan Sieira, Ruben Casado-Arroyo

Published in: Journal of Interventional Cardiac Electrophysiology | Issue 1/2017

Excerpt

A 52-year-old woman with a history of non-ischemic left ventricular dysfunction (EF of 40 %) was brought to the hospital for cardiac arrest. The patient was found at home in ventricular fibrillation and was shocked three times with return of spontaneous circulation. Mild hypokalemia (3.2 mEq/L) was the only contributing factor. …

Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003;107(23):2932–7.CrossRefPubMed

Sweeney MO, Ruetz LL, Belk P, Mullen TJ, Johnson JW, Sheldon T. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias. J Am Coll Cardiol. 2007;50(7):614–22.CrossRefPubMed

Strik M, Defaye P, Eschalier R, Mondoly P, Frontera A, Ritter P, et al. Performance of a specific algorithm to minimize right ventricular pacing: a multicenter study. Heart Rhythm. 2016.

Title: Increased risk of ventricular fibrillation associated with RYTHMIQ™: lessons learned
Authors: Thomas Nguyen
Juan Sieira
Ruben Casado-Arroyo
Publication date: 01-01-2017
Publisher: Springer US
Published in: Journal of Interventional Cardiac Electrophysiology / Issue 1/2017
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI: https://doi.org/10.1007/s10840-016-0177-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Increased risk of ventricular fibrillation associated with RYTHMIQ™: lessons learned

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

National experience with long-term use of the wearable cardioverter defibrillator in patients with cardiomyopathy

Investigation of the atrial conduction time measured by tissue Doppler imaging at the left atrial appendage and the actual electrical conduction time: consideration of left atrial remodeling in atrial fibrillation patients

Intermittent vs. Continuous Anticoagulation theRapy in patiEnts with Atrial Fibrillation (iCARE-AF): a randomized pilot study

Persistent iatrogenic atrial septal defects after pulmonary vein isolation: long-term follow-up with contrast transesophageal echocardiography

Efficacy and safety of the second-generation cryoballoons versus radiofrequency ablation for the treatment of paroxysmal atrial fibrillation: a systematic review and meta-analysis

Remote magnetic navigation for ventricular ablation: did the machine win this round?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page